3 Buy the Dip Candidates to Add on Market Weakness

Wednesday, May 5, 2021 | Sean Sechler
3 Buy the Dip Candidates to Add on Market WeaknessBuying the dip means that you are purchasing an asset or security after it has dropped in price. The idea is that by adding shares of high-quality companies at discounted prices, you can take advantage of bargains and lower your average cost of big positions in your account. With that said, there’s a fine line between buying the dip at the right time and catching a falling knife. It’s important to focus on buying dips of stocks that are in clear long-term uptrends and to define your risk on each purchase just in case there is a big trend shift in the overall market.

We are seeing some market weakness to start the month of May, which means now is a great time to start putting together your shopping list of companies that you’ve been waiting to add at lower prices. These aren’t necessarily stocks that have already dropped a lot in value, but rather stocks that you should feel comfortable with buying should they dip in the coming weeks. Let’s take a look at 3 buy the dip candidates to add on market weakness.

Northrop Grumman (NYSE:NOC)

This leading defense and aerospace company has shown incredible strength this year and is a great company to consider adding on dips. It’s the type of company that investors can buy with conviction, thanks to the fact that it’s an industry leader and a business that will grow regardless of economic conditions. Northrop Grumman earns the majority of its revenue from government contracts and has four main operating segments, aeronautics, defense systems, mission systems, and space systems. It’s also one of the best values in the S&P 500 at this time given that the stock currently trades at a 14.81 forward P/E.

Northrup Grumman is up over 24% year-to-date and the company reported strong Q1 earnings that should give investors even more confidence to add shares on dips. The company saw its sales increase by 6% to $9.2 billion and net earnings increase by 153% year-over-year to $2.2 billion. Perhaps most impressive was the company’s growth in its space business, which generated total revenue up 29% year-over-year. Finally, the fact that this stock continues to show relative strength in a weak market tells us that it’s a company in high demand.

Cigna Corporation (NYSE:CI)

There’s a lot for investors to like about this buy the dip candidate, which is the second-largest U.S. employee benefits organization in terms of total revenues. Cigna Corporation offers health care products and services as well as group life, accident, and disability insurance. It’s a quality name in the health services industry that should see a nice bump in top-line growth this year as unemployment levels improve. Since the company provides medical membership coverage to tons of commercial customers, Cigna stands to benefit greatly from a rebound in the labor market.

Cigna also recently acquired Express Scripts, a pharmacy benefit management organization, which resulted in creating one of the biggest providers of pharmacy benefits and insurance plans. This move should result in nice long-term growth opportunities and cost synergies and is another reason to consider adding the stock on dips. Finally, the fact that the stock offers a 1.59% dividend yield is another great reason to add this company to your long-term investment portfolio.

Facebook (NASDAQ:FB)

Technology stocks have not been the place to be to start the month of May, but that doesn’t mean you should avoid them entirely. Companies like Facebook are getting more and more attractive as their price dips along with the NASDAQ index. The social media giant is a great buy-the-dip candidate thanks to its ridiculously strong earnings and the fact that it is one of the most undervalued mega-cap tech companies based on P/E ratios. Facebook operates the world’s largest portfolio of social networking websites including Facebook, Instagram, Facebook Messenger, and WhatsApp.

The company has changed the way that advertisers sell products thanks to its data-driven direct response advertising and is benefitting from a nice rebound in ad spend following the pandemic. Facebook’s Q1 earnings were nothing short of impressive, as the company reported a 48% increase in revenue and a 93% increase in diluted EPS. The stock gapped up big after the earnings release but has started to pull back, which means that investors should possibly look to add shares shortly after the selloff subsides.

Featured Article: What is the Dow Jones Industrial Average (DJIA)?


7 Hotel Stocks Just Waiting For the Vaccine

Like any group of stocks related to travel and tourism, hotel stocks saw a steep drop in share prices in 2020. The leisure and hospitality sector that once had 15 million employees has lost 4 million jobs since February.

Many major cities will be feeling the ripple effects of the Covid-19 pandemic for years. However, there is ample evidence that shows the pandemic may be coming to an end. The number of new cases is dropping. The number of those getting vaccinated is rising. And even in the cities with the most restrictive mitigation measures, the slow process of reopening is beginning.

All of this can’t come fast enough for individuals who rely on the travel and tourism industry for their livelihood. Hotel chains had at least some revenue coming in the door. And when earnings season concludes, the more budget-friendly hotel chains may realize revenue that is 75% of its 2019 numbers. But that is not enough to bring the hotels to anywhere near full employment. Particularly with hotels that have bars and restaurants that have remained closed or open at limited capacity.

Many economists are optimistic that travel may begin to look more normal by the summer of this year. And the global economy may deliver 6.4% GDP growth this year. With that in mind, the hotel chains with the best fundamentals and the broadest footprint will be in the best position as the economy reopens.

View the "7 Hotel Stocks Just Waiting For the Vaccine".


Companies Mentioned in This Article

CompanyMarketRank™Current PricePrice ChangeDividend YieldP/E RatioConsensus RatingConsensus Price Target
Northrop Grumman (NOC)2.5$373.30+1.7%1.68%13.67Buy$397.00
Cigna (CI)2.8$236.48+1.9%1.69%10.17Buy$285.93
Facebook (FB)2.3$332.24+0.8%N/A28.42Buy$372.54
Compare These Stocks  Add These Stocks to My Watchlist 

MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.